E.I. DuPont de Nemours & Co. (NYSE:DD) and Cold Spring Harbor Laboratory have extended their research collaboration arrangement, which began in 2007, for another five years. This multi-million dollar partnership supports cutting-edge plant research in biology concentrated upon addressing increasing global food demands.
JPMorgan Chase & Co. (NYSE:JPM) will conduct a new $2.6 billion New Jersey bond sale for free, according to the Wall Street Journal. A spokesperson said that this note sale, which was postponed last week due to Sandy, is likely to be priced next week.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Microsoft Corporation’s (NASDAQ:MSFT) long-anticipated iOS (NASDAQ:AAPL) and Anrdoid (NASDAQ:GOOG) versions of Microsoft Office will debut early next year, according to inside sources to The Verge, which cites a recent Microsoft press release from its Czech Republic unit revealed that Office Mobile applications for Android and iOS would be made available by March.
Pfizer (NYSE:PFE) and the specialty biopharmaceutical firm Auxilium Pharmaceuticals (NASDAQ:AUXL) have modified their collaboration agreement for the development, commercialization and production of Xiapex in the European Union and in certain other European and Eurasian countries. Through its terms, the Collaboration Agreement will conclude no later than April 24, 2013, but before the mutual termination date, the parties will continue to perform all of their obligations as required in the Collaboration Agreement. Subsequent to the termination date, all rights to commercialize Xiapex and responsibility for regulatory activities for Xiapex in these countries will revert to Auxilium, which at that point will recognize $94 million of deferred revenue along with $9 million of deferred costs in the fourth quarter.